|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/405 | |||
| A61K 31/47 | |||
| A61K 31/517 | |||
| A61P 11/06 |
| (11) | Number of the document | 3142701 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15724354.4 |
| Date of filing the European patent application | 2015-05-11 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2015/051377 |
| Date | 2015-05-11 |
| (87) | Number | WO 2015/173551 |
| Date | 2015-11-19 |
| (30) | Number | Date | Country code |
| 201408384 | 2014-05-12 | GB | |
| 201417719 | 2014-10-07 | GB |
| (72) |
ABBOTT-BANNER, Katharine, GB
HANRAHAN, John, CA
THOMAS, David, CA
|
| (73) |
Verona Pharma PLC,
One Central Square, Cardiff CF10 1FS,
GB
|
| (54) | NEW TREATMENT |
| NEW TREATMENT |